课题基金 / 基金详情

Characterizing Human Exceptional Longevity

Characterizing Human Exceptional Longevity
人类超长寿命的特征
批准号:
7189048
负责人:
THOMAS T PERLS
金额:
$13.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2011-01-31

项目摘要

项目成果

THOMAS T PERLS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This is a revised application for a Mid-Career Investigator Award in Patient-Oriented Research (K24). The applicant, Dr. Thomas Perls, is an Associate Professor of Medicine and Geriatrics and Founder and Director of the New England Centenarian Study. Having received an NIH physician scientist award (K-12) and a Paul Beeson Faculty Scholar in Aging Research Award, Dr. Perls proceeded to become an independent scientist devoted to patient-oriented research. Specifically, through these earlier mentored awards, Dr. Perls developed expertise in conducting a population-based phenotypic study of an extremely old cohort. His independence is demonstrated by his receipt of four other NIH grants (RO-3, R-21 and two R0-1s). Dr. Perls has a substantial record of mentoring students and clinical investigators at various stages of their careers. He has mentored five American Federation of Aging Research Medical Student Geriatrics Scholars, three premedical and pre-graduate school students, two geriatrics fellows, a pre-doctoral fellow and an Assistant Professor in Geriatrics. All of these trainees successfully published papers with Dr. Perls. While carrying out the aims of his R01-funded study, a population-based bio-demographic study of centenarians and their families, this K24 grant provides that 15% effort will be devoted to gathering preliminary data and developing applications to fund a genetic epidemiological study of centenarians. Dr. Perls will attend courses in bioethics, responsible conduct of clinical investigations and genetic epidemiology as a part of his career development-related education goals. These centenarian studies provide fertile ground for mentees to gain hands-on experience in clinical research. Innumerable aspects of exceptional longevity are available for study from spirituality, personality, adaptive capacity and functional reserve, to demographic and clinical observations to epigenetic associations. 35% effort will be dedicated to mentoring established and future mentees. A large and diverse academic community with a broad spectrum of training programs will ensure an ample pool of highly qualified and talented mentees. Relevance to public health: The study of human exceptional longevity under Dr. Perls's mentorship, provides trainees, from students to junior faculty, fertile ground for studying a broad range of aspects of successful aging from religion, personality, adaptive capacity and functional reserve to environmental, behavioral and genetic associations with exceptional survival. Subsequent findings may ultimately translate into strategies that help people age more successfully.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
  • 批准号:
    10276390
  • 项目类别:
  • 资助金额:
    $20.08万
  • 财政年份:
    2021
  • 负责人:
    THOMAS T PERLS
  • 依托单位:
Administrative Core
  • 批准号:
    10689331
  • 项目类别:
  • 资助金额:
    $19.1万
  • 财政年份:
    2021
  • 负责人:
    THOMAS T PERLS
  • 依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
  • 批准号:
    10017131
  • 项目类别:
  • 资助金额:
    $430.23万
  • 财政年份:
    2019
  • 负责人:
    THOMAS T PERLS
  • 依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
  • 批准号:
    10678171
  • 项目类别:
  • 资助金额:
    $499.8万
  • 财政年份:
    2019
  • 负责人:
    THOMAS T PERLS
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: